Andersons pediatric cardiology 582

arrhythmiasyndromes:documentendorsedby
HRS,EHRA,andAPHRSinMay2013andby
ACCF,AHA,PACES,andAEPCinJune2013.
HeartRhythm.2013;10(12):1932–1963.
139.BerulCI,etal.Resultsofamulticenter
retrospectiveimplantablecardioverterdefibrillatorregistryofpediatricandcongenital
heartdiseasepatients.JAmCollCardiol.
2008;51(17):1685–1691.
140.GarnreiterJM,etal.InappropriateICDshocksin
pediatricsandcongenitalheartdiseasepatients:
riskfactorsandprogrammingstrategies.Heart
Rhythm.2015;12(5):937–942.
141.NapolitanoC,PrioriSG.Diagnosisand
treatmentofcatecholaminergicpolymorphic
ventriculartachycardia.HeartRhythm.
2007;4(5):675–678.
142.LahatH,etal.Amissensemutationinahighly
conservedregionofCASQ2isassociatedwith
autosomalrecessivecatecholamine-induced
polymorphicventriculartachycardiainBedouin
familiesfromIsrael.AmJHumGenet.
2001;69(6):1378–1384.
143.PrioriSG,ChenSR.Inheriteddysfunctionof
sarcoplasmicreticulumCa2+handlingand
arrhythmogenesis.CircRes.2011;108(7):871–
883.


144.KannankerilPJ,etal.Efficacyofflecainidein
thetreatmentofcatecholaminergicpolymorphic
ventriculartachycardia:arandomizedclinical

trial.JAMACardiol.2017;2(7):759–766.
145.RostonTM,etal.Catecholaminergic
polymorphicventriculartachycardiainchildren:
analysisoftherapeuticstrategiesandoutcomes
fromaninternationalmulticenterregistry.Circ
ArrhythmElectrophysiol.2015;8(3):633–642.
146.DiDiegoJM,etal.Ionicandcellularbasisfor
thepredominanceoftheBrugadasyndrome
phenotypeinmales.Circulation.
2002;106(15):2004–2011.
147.VerheugtCL,etal.Theemergingburdenof
hospitaladmissionsofadultswithcongenital
heartdisease.Heart.2010;96(11):872–878.
148.LabombardaF,etal.Increasingprevalenceof
atrialfibrillationandpermanentatrial
arrhythmiasincongenitalheartdisease.JAm
CollCardiol.2017;70(7):857–865.
149.KhairyP,etal.PACES/HRSexpertconsensus
statementontherecognitionandmanagementof
arrhythmiasinadultcongenitalheartdisease:
developedinpartnershipbetweenthePediatric
andCongenitalElectrophysiologySociety
(PACES)andtheHeartRhythmSociety(HRS).
EndorsedbythegoverningbodiesofPACES,


HRS,theAmericanCollegeofCardiology
(ACC),theAmericanHeartAssociation(AHA),
theEuropeanHeartRhythmAssociation
(EHRA),theCanadianHeartRhythmSociety

(CHRS),andtheInternationalSocietyforAdult
CongenitalHeartDisease(ISACHD).CanJ
Cardiol.2014;30(10):e1–e63.
150.HoyerAW,BalajiS.Thesafetyandefficacyof
ibutilideinchildrenandinpatientswith
congenitalheartdisease.PacingClin
Electrophysiol.2007;30(8):1003–1008.
151.RaoSO,etal.Atrialtachycardiasinyoung
adultsandadolescentswithcongenitalheart
disease:conversionusingsingledoseoral
sotalol.IntJCardiol.2009;136(3):253–257.
152.TriedmanJK,etal.Radiofrequencyablationof
intra-atrialreentranttachycardiaaftersurgical
palliationofcongenitalheartdisease.
Circulation.1995;91(3):707–714.
153.SeslarSP,etal.Ablationofnonautomaticfocal
atrialtachycardiainchildrenandadultswith
congenitalheartdisease.JCardiovasc
Electrophysiol.2006;17(4):359–365.
154.KhairyP,etal.Riskstratificationinsurgically
repairedtetralogyofFallot.ExpertRev
CardiovascTher.2009;7(7):755–762.
155.KhairyP.Suddencardiacdeathintransposition